The usage and dosage of Enasidenib should strictly follow the standard protocol, while paying attention to specific food taboos to avoid drug interactions. The following provides a detailed explanation from three aspects: administration plan, dosage adjustment, and dietary taboos, to ensure the maximum safety and efficacy of medication.
1. Usage and dosage
(1) Standard dose: It is recommended to take 100mg orally once a day, whole tablets should be swallowed, and should not be crushed or chewed.
(2) Medication time: It is recommended to take it at a fixed time (such as after breakfast), on an empty stomach or with meals, but consistency should be maintained.
(3) Omission treatment: If the missed dose exceeds 12 hours, skip the daily dose and continue to administer according to the original plan the next day; You can take it immediately within 12 hours.
2. Adjustment for special populations
(1) Liver dysfunction: Mild to moderate damage does not require adjustment, severe (Child Pugh C grade) is contraindicated.
(2) Renal insufficiency: Mild to moderate, no adjustment needed. Use with caution in patients with end-stage renal disease or dialysis due to insufficient data.
(3) Elderly patients: those aged 65 and above do not need adjustment, but need to strengthen adverse reaction monitoring.
3. Forbidden foods
(1) Grapefruit/grapefruit: may inhibit CYP3A4 metabolic enzymes, increase drug blood concentration and toxicity risk.
(2) High fat diet: may delay drug absorption, it is recommended to avoid taking with high-fat foods.
(3) Alcohol: It may increase the burden on liver function, especially for patients with liver dysfunction who should strictly abstain from alcohol.
Disclaimer:《Usage, dosage, and contraindications of Enasidenib》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication!
Full Name:Idhifa、Enasidenib、恩西地平
Reference Price:$1215.00
Prescribing Information: 恩西地平的创新疗法为AML患者,尤其是传统治疗无效或复发的患者,提供了新的治疗选择。 一、药品名称 1、通用名: 恩西地平(Enasidenib) 2、商品名: IDHIFA® 二、适应症 用于治疗经FDA批准检测确认存在异柠檬酸脱氢酶-2...